Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Transfection Reagents And Equipment Market be in 2030 compared with 2026?
The transfection reagents and equipment market has experienced rapid expansion in recent years. This market is projected to increase from $1.74 billion in 2025 to $1.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.2%. The historical growth can be attributed to several factors, including the expansion of molecular biology research activities, the increasing use of cell-based assays, the growth of recombinant protein production, rising academic and industrial genomics research, and the availability of advanced transfection chemistries.
The transfection reagents and equipment market is projected to experience substantial growth over the coming years, anticipated to reach $2.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period can be ascribed to factors such as the growing integration of CRISPR and gene therapy research, a surging need for scalable transfection platforms, the broadening of biopharmaceutical pipeline development, increasing capital allocation in precision medicine, and enhanced automation within life science laboratories. Key trends expected over the forecast horizon encompass the heightened embrace of high-efficiency transfection reagents, an escalating demand for delivery systems compatible with gene editing, the expanding application of non-viral transfection techniques, the proliferation of automated transfection instruments, and a sharpened emphasis on cell-type specific transfection solutions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp
What Drivers Are Guiding Growth Patterns In The Transfection Reagents And Equipment Market?
The increasing global population of cancer patients is anticipated to fuel the expansion of the transfection reagents and equipment market. This condition, cancer, involves the abnormal and uncontrolled proliferation of cells. Transfection reagents are frequently employed in oncology research to insert external genetic material, like plasmid DNA or RNA molecules. This enables scientists to explore different facets of cancer biology, including gene expression analysis, gene silencing techniques, drug screening, and target validation. As an illustration, projections released in July 2024 by Cancer Research UK, a charity based in the UK, indicate that cancer incidence rates in the United Kingdom are forecasted to climb for the majority of cancer types between 2023-2025 and 2038-2040. These increases vary from less than 1% for breast cancer to 50% for eye cancer. Conversely, a minority of cancers are expected to show a decrease, with reductions spanning from 2% for lung cancer to 27% for mesothelioma. Consequently, the global rise in cancer patient numbers is a key factor propelling the expansion of the transfection reagents and equipment market.
How Is The Transfection Reagents And Equipment Market Divided Into Segments?
The transfection reagents and equipment market covered in this report is segmented –
1) By Product: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By End User: Biopharma, Contract Research Organizations (CROs), Academia
Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits
Which Trends Are Influencing The Development Of The Transfection Reagents And Equipment Market?
Major companies in the transfection reagents and equipment market are prioritizing the development of innovative advancements like GMP-grade AAV transfection reagents, aiming to enhance viral vector production efficiency and support extensive gene therapy manufacturing. A GMP-grade AAV transfection reagent represents a chemically formulated product compliant with regulatory standards, designed to facilitate the high-efficiency delivery of genetic material into suspension cell cultures for the scalable generation of recombinant adeno-associated virus vectors. As an illustration, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, attained U.S. Food and Drug Administration Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade. This reagent exhibits substantially elevated viral titers and significantly improved full capsid ratios across multiple adeno-associated virus serotypes, thus offering superior performance compared to conventional formulations. Moreover, it optimizes manufacturing efficiency by achieving comparable vector yields with reduced reagent consumption, all while adhering to the stringent regulatory and quality criteria necessary for clinical and commercial gene therapy production.
Which Key Market Players Are Investing In Expansion And Innovation Within The Transfection Reagents And Equipment Market?
Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Transfection Reagents And Equipment Market In The Coming Years?
North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Transfection Reagents And Equipment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10780&type=smp
Browse Through More Reports Similar to the Global Transfection Reagents And Equipment Market 2026, By The Business Research Company
Biotechnology Reagents Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report
Sterilization Equipment And Disinfectants Market 2026
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market
Sequencing Reagents Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company